Full name
TERAPIA MEDYCZNA "TERAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
TERAPIA MEDYCZNA "TERAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. KOSTRZYŃSKA 3, 61-042 POZNAŃ
TAX ID7792083582
Rate company:
TERAPIA MEDYCZNA "TERAMED" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7792083582
KRS0000067913
Share capital51,000.00 zł
address
UL. KOSTRZYŃSKA 3, 61-042 POZNAŃ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7792083582
REGON
639646948
KRS
0000067913
Legal form
limited liability company
Register Address
UL. KOSTRZYŃSKA 3, 61-042 POZNAŃ
Date of registration in KRS
2001-12-07
Date of commencement of economic activity
2001-12-07
Act signature
RDF/654721/24/612
Pkd codes
86.21.Z - General medical practice activities
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
68.20.Z - Rental and operating of own or leased real estate
70.22.Z - Business and other management consultancy activities
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL37 2030 0045 1110 0000 0041 1980 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,2 | -0,1 | 0,2 | 461,7 |
Gross profit (loss) | 0,4 | 0,2 | 0,6 | 183,7 |
EBITDA | 0,6 | 0,5 | 0,9 | 67,9 |
Short time liabilities | 0,4 | 0,5 | 0,5 | 9,7 |
Other operating costs | 0 | 0 | 0 | -57,5 |
Equity capital | 1,5 | 1,7 | 2,2 | 33,6 |
Operating profit (EBIT) | 0,4 | 0,2 | 0,6 | 164 |
Assets | 1,8 | 2,1 | 2,7 | 28,4 |
Net profit (loss) | 0,4 | 0,2 | 0,6 | 188,8 |
Cash | 0,2 | 0,5 | 1,1 | 105,5 |
Net income from sale | 4,8 | 5,2 | 6,4 | 21,8 |
Liabilities and provisions for liabilities | 0,4 | 0,5 | 0,5 | 9,7 |
Working assets | 0,8 | 1,2 | 1,7 | 46 |
Other income costs | 0,3 | 0,3 | 0,4 | 36,7 |
Depreciation | 0,2 | 0,3 | 0,2 | -12,4 |
% | % | % | p.p. | |
Profitability of capital | 25,1 | 11,6 | 25,1 | 13,5 |
Equity capital to total assets | 79,4 | 78,3 | 81,5 | 3,2 |
Gross profit margin | 8,5 | 4,2 | 9,7 | 5,5 |
EBITDA Margin | 13,6 | 9,7 | 13,4 | 3,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 32 | 29 | -3 |
Current financial liquidity indicator | 2.0634384155273438 | 2.603342294692993 | 3.4667787551879883 | 0,9 |
Net dept to EBITDA | -0.3687579035758972 | -1.0431678295135498 | -1.2763811349868774 | -0,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download xades01-01-2023 - 31-12-2023
Activity report
Download xades01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download xadesShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.